Skip to main content
    S

    Structure Therapeutics Inc. American Depositary Shares (GPCR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $18.17
    -0.40 (-2.15%)

    Market Cap: $1.33B

    Last updated: Nov 17, 2026 at 4:36 PM ET

    Structure Therapeutics Inc. American Depositary Shares (GPCR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Structure Therapeutics Inc. American Depositary Shares (GPCR) has a market cap of $1.33B. Its share count is up 24.57% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$1.33B
    Latest price (Nov 17, 2026)$18.17

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.29% in the quarter ended Sep 30, 2026 and grew 12.85% a year over 2 years.

    Shares Outstanding72.86M
    Shares Change (YoY)+24.57%
    Shares Change (QoQ)+0.29%
    Share Count Growth (2Y CAGR)+12.85%

    Price Statistics

    The stock is down 50.65% over 52 weeks and trades 32.38% below its 50-day average.

    Beta (1Y)1.29
    52-Week Change-50.65%
    1-Month Change-17.45%
    3-Month Change-66.43%
    6-Month Change-49.36%
    Total Return (1Y)-50.65%
    Total Return (3Y CAGR)-30.34%
    Return vs SPY (1Y)-58.89%
    Max Drawdown (1Y)-80.63%
    Max Drawdown (3Y)-80.63%
    Sharpe Ratio (1Y)-0.69
    Correlation with SPY (1Y)0.19
    50-Day Average$26.87
    200-Day Average$44.90
    52-Week Range$18.38 to $94.90
    RSI (14 Days)27.6
    Average Volume (20 Days)926.24K

    Price chart

    Financial Position

    Current assets cover 11.91x current liabilities.

    Current Ratio11.91x
    Quick Ratio11.91x

    Returns and Efficiency

    Return on equity is -24.07% and return on assets is -22.04% over the last 12 months.

    Return on Equity (ROE)-24.07%
    Return on Assets (ROA)-22.04%
    Return on Capital Employed (ROCE)-23.90%
    ROA (5Y Average)-25.90%
    ROIC (5Y Average)12.84%

    Scores

    GPCR has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$340.62M
    Pretax Income-$293.34M
    Net Income-$294.11M
    EBITDA-$291.74M
    EBIT-$293.34M
    Reported EPS (TTM)-$1.99

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 91.73% of the $1.33B in total assets.

    Cash and Equivalents$222.03M
    Working Capital$1.17B
    Shareholder Equity$1.22B
    Total Assets$1.33B
    Total Liabilities$112.55M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $6.37M of capital spending, operating cash flow left -$277.32M of free cash flow.

    Operating Cash Flow-$270.95M
    Capital Expenditures$6.37M
    Free Cash Flow-$277.32M
    FCF Per Share-$3.87
    Depreciation and Amortization$1.60M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    GPCR does not pay a dividend. Its free cash flow yield is -20.95%.

    FCF Yield-20.95%
    Shareholder Yield0.00%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About GPCR

    What is GPCR's market cap?

    Structure Therapeutics Inc. American Depositary Shares has a market cap of $1.33B.

    How many shares of GPCR are outstanding?

    Structure Therapeutics Inc. American Depositary Shares has 72.86M shares outstanding. The count is up 24.57% from a year earlier.

    Does GPCR pay a dividend?

    No. Structure Therapeutics Inc. American Depositary Shares does not pay a dividend.